Post-stroke Cognitive Impairment and Dementia
GRECogVASC
2 other identifiers
interventional
1,635
1 country
7
Brief Summary
Projections from epidemiological studies suggest that, among the Western adult population, one in three will present a cerebrovascular accident (stroke), severe cognitive disorders, or both. To better diagnose the Vascular Cognitive Impairment, new standards were developed by a North America working group which are under validation. It is essential to adapt these standard for French-speaking population, and especially to define cutoff scores of the cognitive battery to determine cognitive deficit. The investigators propose a study coordinated by the University-Hospital of Amiens for french speaking centers. This study will investigate this battery with 906 controls to define the standards and 302 stroke affected patients to define the frequency and cognitive mechanisms. This step is essential for people to benefit from these new standards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Aug 2010
Longer than P75 for not_applicable stroke
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 22, 2011
CompletedFirst Posted
Study publicly available on registry
April 20, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedSeptember 19, 2025
September 1, 2025
6.3 years
February 22, 2011
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
determine the frequency of cognitive and behavioral disorders 6 months post-stroke assessed with this new NINDS-Canadian Stroke Network battery
deficit (as compared with control performance) on battery of tests assessing instrumental (oral naming, copy of complex figure)and executive fucntions (verbal fluency, Trail Making, reaction time tests), episodic memory for verbal and visual materials and behavioral changes
6 month
Secondary Outcomes (2)
determine the proportion of patients with dementia
6 month
determine the value of cognitive screening tests
6 month
Study Arms (1)
Behavioral
EXPERIMENTALBehavioral: French adaptation of NINDS-Canadian Stroke Network battery
Interventions
* clinical: post-stroke neurological follow-up assessment * neuropsychological: comprising the NINDS-Canadian Stroke Network neuropsychological battery * MRI
Eligibility Criteria
You may qualify if:
- Patients:management at the acute phase (duration \< 30 days) of stroke visualized by imaging, age between 40 and 80 years, French-speaking, reliable informant, agreeing to participate in the study.
- Controls: derived from the general population and consenting to participate in the study.
You may not qualify if:
- Patients: mental retardation, illiteracy, known dementia, schizophrenia or psychosis or history of psychiatric illness requiring a stay for \> 2 days in a psychiatry unit, comorbidities affecting cognition, persistent disturbance of consciousness, contraindication to MRI.
- Controls: illiteracy, deficit on MMSE (Mini-Mental State Examination), visual, auditory or motor deficit, history of brain disease or psychiatric illness (schizophrenia or other psychosis) or ongoing psychiatric illness (depression or other) currently requiring treatment or requiring a stay \> 2 days in psychiatry unit or anxiety requiring more than one medication at the present time, alcoholism, opiate or illicit drug use \< 3 months, ongoing antidepressant or antiepileptic treatment, recent anxiolytic or hypnotic treatment, general anaesthesia \< 3 months, history of heart surgery with cardiopulmonary bypass
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHRU Lille
Lille, Pas-de-calais, 59000, France
CHU Amiens
Amiens, Picardie, 80000, France
CHU Brest
Brest, 29200, France
CHU Dijon
Dijon, 21000, France
CH La Rochelle
La Rochelle, 17000, France
HIA Val de Grâce
Paris, 75000, France
CHU Saint Etienne
Saint-Etienne, 42000, France
Related Publications (6)
Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 2011 Jun;42(6):1712-6. doi: 10.1161/STROKEAHA.110.606277. Epub 2011 Apr 7.
PMID: 21474808BACKGROUNDGodefroy O, Just A, Ghitu A, Leclercq C, Garcia PY, Lamy C, Canaple S, Bugnicourt JM. The Rankin scale with revised structured interview: effect on reliability, grading of disability and detection of dementia. Int J Stroke. 2012 Feb;7(2):183. doi: 10.1111/j.1747-4949.2011.00743.x. No abstract available.
PMID: 22264374BACKGROUNDGodefroy O; GRECOG-VASC study group; Leclercq C, Bugnicourt JM, Roussel M, Moroni C, Quaglino V, Beaunieux H, Taillia H, Nedelec-Ciceri C, Bonnin C, Thomas-Anterion C, Varvat J, Aboulafia-Brakha T, Assal F. Neuropsychological assessment and cerebral vascular disease: the new standards. Rev Neurol (Paris). 2013 Oct;169(10):779-85. doi: 10.1016/j.neurol.2013.07.009. Epub 2013 Aug 30.
PMID: 23999023RESULTGodefroy O, Leclercq C, Roussel M, Moroni C, Quaglino V, Beaunieux H, Tallia H, Nedelec-Ciceri C, Bonnin C, Thomas-Anterion C, Varvat J, Aboulafia-Brakha T, Assal F; GRECOG-VASC Neuropsychological Committee. French adaptation of the vascular cognitive impairment harmonization standards: the GRECOG-VASC study. Int J Stroke. 2012 Jun;7(4):362-3. doi: 10.1111/j.1747-4949.2012.00794.x. No abstract available.
PMID: 22583525RESULTBarbay M, Taillia H, Nedelec-Ciceri C, Bompaire F, Bonnin C, Varvat J, Grangette F, Diouf M, Wiener E, Mas JL, Roussel M, Godefroy O; GRECOG-VASC Study Group. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit. Stroke. 2018 May;49(5):1141-1147. doi: 10.1161/STROKEAHA.117.018889. Epub 2018 Apr 11.
PMID: 29643258RESULTGodefroy O, Yaiche H, Taillia H, Bompaire F, Nedelec-Ciceri C, Bonnin C, Varvat J, Vincent-Grangette F, Diouf M, Mas JL, Canaple S, Lamy C, Arnoux A, Leclercq C, Tasseel-Ponche S, Roussel M, Barbay M; GRECogVASC Study Group. Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score. Neurology. 2018 Nov 20;91(21):e1979-e1987. doi: 10.1212/WNL.0000000000006544. Epub 2018 Oct 17.
PMID: 30333160RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Olivier Godefroy, PhD-MD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Hilde Henon, MD
CHRU LILLE
- PRINCIPAL INVESTIGATOR
Hervé Taillia, PhD-MD
HIA val de grace
- PRINCIPAL INVESTIGATOR
Serge Timsit, PhD-MD
CHU Brest
- PRINCIPAL INVESTIGATOR
Claudine Nedelec, MD
CH La Rochelle
- PRINCIPAL INVESTIGATOR
catherine thomas, MD
CHU SAINT-ETIENNE
- PRINCIPAL INVESTIGATOR
Maurice Giroud, PhD-MD
CHU Dijon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2011
First Posted
April 20, 2011
Study Start
August 1, 2010
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
September 19, 2025
Record last verified: 2025-09